Glenmark Pharmaceuticals Fundamentals
P/E Ratio
55.49
P/B Ratio
5.92
Div. Yield
0.12
Sector P/E
60.59
Sector P/B
3.25
Sec. Div. Yield
0.59
Glenmark Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 55.49, compared to the sector average of 60.59. Its P/B Ratio stands at 5.92, while the sector’s is 3.25. In terms of returns, the stock offers a Dividend Yield of 0.12%, which is than the sector’s 0.59%.
Glenmark Pharmaceuticals Score Card
Price
Expensive
Growth
Moderate
Quality
Good
Management
Good
On its scorecard, Glenmark Pharmaceuticals reflects: Price – Expensive, Growth – Moderate, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Glenmark Pharmaceuticals Associated Pages
- Glenmark Pharmaceuticals Share Price
- Glenmark Pharmaceuticals Share Price chart
- Glenmark Pharmaceuticals Technical Analysis
- Glenmark Pharmaceuticals Peer Comparison
- Glenmark Pharmaceuticals Share Price History
- Glenmark Pharmaceuticals Dividend
- Glenmark Pharmaceuticals Board of Directors
- Glenmark Pharmaceuticals Shareholding Pattern
